A nonsynonymous LNK polymorphism associated with idiopathic erythrocytosis

American Journal of Hematology

Volumn 86, Issue 11, 2011, Pages 962-964

  Mcmullin, Mary Frances ^a,b   Wu, Chao ^c   Percy, Melanie J ^b   Tong, Wei ^c  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ERYTHROPOIETIN; LYMPHOCYTE SPECIFIC ADAPTOR PROTEIN; PROTEIN SH2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; ERYTHROCYTOSIS; FEMALE; GENETIC ASSOCIATION; GENETIC SCREENING; HETEROZYGOTE DETECTION; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; IDIOPATHIC ERYTHROCYTOSIS; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BASE SEQUENCE; CELLS, CULTURED; COHORT STUDIES; ERYTHROPOIETIN; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION STUDIES; HEMATOPOIETIC STEM CELLS; HUMANS; JANUS KINASE 2; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NORTHERN IRELAND; POLYCYTHEMIA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 80054033431     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22154     Document Type: Article

References (21)

1. McMullin MF. HIF pathway mutations and erythrocytosis. Expert Rev Hematol 2010; 3: 93-101.
2. Percy MJ. Genetically heterogeneous origins of idiopathic erythrocytosis. Hematology 2007; 12: 131-139.
3. Lasho TL, Pardanani A, Tefferi A. LNK mutations in JAK2 mutation-negative erythrocytosis. N Engl J Med 2010; 363: 1189-1190.
4. Oh ST, Simonds EF, Jones C, et al. Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signalling in patients with myeloprolifetrative neoplasms. Blood 2010; 116: 988-992.
5. Bersenev A, Wu C, Balcerek J, Tong W. Lnk controls mouse hematopoeitic stem cell self-renewal and quiescence through direct interactions with myeloproliferative disorders. J Clin Invest 2008; 118: 2832-2844.
6. Tong W, Lodish HF. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis. J Exp Med 2004; 200: 569-580.
7. Tong W, Zhang J, Lodish HF. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signalling pathways. Blood 2005; 105: 4604-4612.
8. Bersenev A, Wu C, Balcerek J, et al. Lnk constrains myeloproliferative diseases in mice. J Clin Invest 2010; 120: 2058-2069.
9. Oh ST, Zahn JM, Jones CD, et al. Identification of novel LNK mutations in patients with chronic myeloproliferative neoplasms and related disorders. Blood 2010; 116: 315.
10. Lasho T, Tefferi A, Vannucchi AM, et al. LNK mutation studies in chronic and blast-phase myeloproliferative neoplasms and JAK2 mutation-negative erythrocytosis. Blood 2010; 116: 4105.
11. Pardanani A, Lasho T, Finke C, et al. LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations. Leukemia 2010; 24: 1713-1718.
12. Lavrikova EY, Nikitin AG, Kuraeva TL, et al. The carriage of the type I diabetes associated R262W variant of human LNK correlates with increased proliferation of peripheral blood monocytes in diabetic patients. Pediatr Diabetes 2011; 12: 127-132.
13. Hunt KA, Zhernakova A, Turner G, et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 2008; 40: 395-402.
14. Smyth DJ, Plagnol V, Walker NM, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008; 359: 2767-2777.
15. Newton-Cheh C, Johnson T, Gateva V, et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009; 41: 666-676.
16. Levy D, Ehret GB, Rice K, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet 2009; 41: 677-687.
17. Gudbjartsson DF, Bjornsdottir US, Halapi E, et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 2009; 41: 342-347.
18. Gery S, Cao Q, Gueller S, et al. Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F. J Leukoc Biol 2009; 85: 957-965.
19. Baran-Marszak F, Magdoud H, Desterke C, et al. Expression level and differential JAK2-V617F-binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms. Blood 2010; 116: 5961-5971.
20. McMullin MF, Bareford D, Campbell P, et al. Guidelines for the diagnosis, investigation and management of polycythaemia/erythro-cytosis. Br J Haematol 2005; 130: 174-195.
21. Ye S, Dhillon S, Ke X, Collins AR, Day IN. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 2001; 29: E88-8.